Showing results (171-180 of 286) with videos related to
Sort By:
Pageof 29
Journal of Surgical Oncology|January 1, 1979
Adriamycin in localized and metastatic uterine sarcomasM S Piver, J J Barlow, S B Lele, et al.Cancer Genetics and Cytogenetics|August 25, 1999
Classification of IVS1-10T-->C as a polymorphism of BRCA1S Fetzer, H A Tworek, M S Piver, et al.American Journal of Obstetrics and Gynecology|June 1, 1975
Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy, and radiation therapyM S Piver, J J Barlow, F J Lee, et al.Gynecologic Oncology|July 1, 1999
Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancerG H Eltabbakh, N Natarajan, M S Piver, et al.Cancer|March 15, 1994
Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancerM S Piver, F O Recio, T R Baker, et al.Cancer|October 1, 1989
Metastatic patterns in histologic variants of ovarian cancer. An autopsy studyP G Rose, M S Piver, Y Tsukada, et al.Gynecologic Oncology|September 1, 1992
Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapyM S Piver, J Malfetano, T R Baker, et al.Gynecologic Oncology|July 1, 1997
Age at onset of ovarian cancer in women with a strong family history of ovarian cancerJ M Goldberg, M S Piver, M F Jishi, et al.Cancer Detection and Prevention|January 1, 1997
Tubal ligation and the risk of ovarian carcinomaT L Cornelison, N Natarajan, M S Piver, et al.Gynecologic Oncology|July 1, 1984
Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervixM S Piver, J J Barlow, S B Lele, et al.Pageof 29